Format

Send to

Choose Destination
Urol Ann. 2019 Apr-Jun;11(2):219-221. doi: 10.4103/UA.UA_53_18.

Nine-year survival after iterative metastasectomies for renal cell carcinoma.

Author information

1
Department of Urology, University Hospitals Leuven, Leuven, Belgium.
2
Department of Urology, Santa Maria Hospital, Lisbon, Portugal.
3
Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.

Abstract

We report the case of a 24-year-old male, diagnosed with an incidental T3a papillary renal cell carcinoma (RCC), treated with left laparoscopic radical nephrectomy. After 7 months, nodal recurrence was identified and retroperitoneal lymph node dissection (RPLND) was performed. Four months later, due to local recurrence, the patient underwent salvage RPLND, partial psoas resection and left adrenalectomy, and remained without recurrence during the following 15 months, after which treatment with sunitinib was started due to multiple metastases in pelvic lymph nodes, lungs, and bone. After 4 years of stable disease, progression at the quadratus lumborum and psoas muscles led to subsequent metastasectomy. No evidence of progression was identified for 2 years, after which, despite multimodal treatment (axitinib and radiotherapy to bone lesions), widespread disease progression led to patient death. This uncommon case of prolonged survival with metastatic RCC highlights the possible role of iterative metastasectomies in the management of advanced stage disease, as well as its potential to extend the survival substantially, even when progressive on tyrosine kinase inhibitors.

KEYWORDS:

Metastasectomy; metastases; mortality; renal cell carcinoma; tyrosine kinase inhibitor

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center